Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2021 / Cilt: 29 - Sayı: 3

Factors affecting the recurrence in patients with venous thromboembolism: A retrospective cohort study

Venöz tromboemboli olgularında nüks gelişimini etkileyen faktörler: Retrospektif kohort çalışması

Pages
384–390
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The presence of deep vein thrombosis, idiopathic events, high D-dimer levels at the end of the first year and hereditary risk factors seem to be associated with recurrence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of the study was to evaluate the frequency of recurrence and the risk factors for recurrence in patients who were diagnosed with venous thromboembolism.
📊
Key Findings & Data:Methods: Between January 2005 and January 2015, a total of 412 venous thromboembolism patients (164 males, 248 females; mean age: 53.5±16.6 years; range: 19 to 95 years) were retrospectively analyzed.
💡
Conclusion & Impact:Conclusion: The presence of deep vein thrombosis, idiopathic events, high D-dimer levels at the end of the first year and hereditary risk factors seem to be associated with recurrence.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: The aim of the study was to evaluate the frequency of recurrence and the risk factors for recurrence in patients who were diagnosed with venous thromboembolism. Methods: Between January 2005 and January 2015, a total of 412 venous thromboembolism patients (164 males, 248 females; mean age: 53.5±16.6 years; range: 19 to 95 years) were retrospectively analyzed. The demographics, underlying risk factors, comorbidities, imaging findings, and treatment data of the patients were recorded. Results: At least one transient/permanent risk factor was found in 341 (82.7%) of the index events, and the other 71 (17.2%) were idiopathic. Recurrence developed in 76 (18.4%) of the patients. The duration of the treatment in the first event was significantly longer in recurrent cases (p=0.007). The recurrence rate in patients diagnosed with only deep vein thrombosis or patients diagnosed with pulmonary thromboembolism + deep vein thrombosis was significantly higher than the patients diagnosed with only pulmonary thromboembolism (24% vs. 14.2%, respectively; p=0.007). The rate of idiopathic venous thromboembolism was higher in recurrent cases than in non-recurrent cases (26.3% vs. 15.2%, respectively; p=0.028). At the end of the first year, the mean D-dimer levels were higher in recurrent cases (p=0.034). Hereditary risk factors were also higher in recurrent cases (39.5% vs. 19.3%, respectively; p=0.031). There was no significant correlation between recurrence and mortality. Conclusion: The presence of deep vein thrombosis, idiopathic events, high D-dimer levels at the end of the first year and hereditary risk factors seem to be associated with recurrence.

Özet

Amaç: Bu çalışmada venöz tromboemboli tanısı konan hastalarda nüks sıklığı ve nüksün risk faktörleri incelendi. Çalışma planı: Ocak 2005 - Ocak 2015 tarihleri arasında toplam 412 venöz tromboemboli hastası (164 erkek, 248 kadın; ort. yaş: 53.5±16.6 yıl; dağılım: 19-95 yıl) retrospektif olarak incelendi. Hastaların demografik özellikleri, altta yatan risk faktörleri, eşlik eden hastalıkları, görüntüleme bulguları ve tedavi verileri kaydedildi. Bulgular: İndeks olguların 341’inde (%82.7) en az bir geçici/kalıcı risk faktörü bulunurken, 71’i (%17.2) idiyopatik idi. İndeks olguların 76’sında (%18.4) nüks gelişti. İlk ataktaki tedavi süresi, nüks gelişen olgularda anlamlı düzeyde daha uzundu (p=0.007). Tek başına derin ven trombozu veya pulmoner tromboemboli + derin ven trombozu ile tanılanan hastalarda nüks oranı, tek başına pulmoner tromboemboli ile tanılanan hastalara kıyasla anlamlı düzeyde yüksek idi (sırasıyla, %14.2’ye kıyasla %24; p=0.007). Nüks gelişmeyen hastalara kıyasla, nüks gelişen hastalarda idiyopatik venöz tromboemboli oranı daha yüksek idi (sırasıyla, %15.2’ye kıyasla %26.3; p=0.028). Birinci yılın sonunda ortalama D-dimer düzeyleri nüks gelişen hastalarda daha yüksekti (p=0.034). Nüks gelişen olgularda kalıtsal risk faktörleri de (sırasıyla, %19.3’e kıyasla %39.5; p=0.031) yüksek bulundu. Nüks ve mortalite arasında anlamlı bir ilişki saptanmadı. Sonuç: Derin ven trombozu, idiyopatik olaylar, birinci yılın sonunda yüksek D-dimer düzeyleri ve kalıtsal risk faktörleri varlığının nüks ile ilişkili olduğu görülmektedir.

🔖

Cite This Article

Bingöl, Z., Okumuş, G., Ateş, Y., Arseven, O. (2022). Factors affecting the recurrence in patients with venous thromboembolism: A retrospective cohort study. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 29 - Sayı: 3, 384–390. https://ajindex.com/articles/423603

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999;82:610-9
  2. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: Results from the Copenhagen City Heart Study. Circulation 2010;121:1896-903
  3. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279:458-62
  4. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med 2000;160:761-8
  5. Ruíz-Giménez N, Suárez C, González R, Nieto JA, Todolí JA, Samperiz AL, et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008;100:26-31
  6. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study. Lancet 2003;362:523-6
  7. Boutitie F, Pinede L, Schulman S, Agnelli G, Raskob G, Julian J, et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: Analysis of individual participants' data from seven trials. BMJ 2011;342:d3036
  8. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006;355:1780-9
  9. Carrier M, Rodger MA, Wells PS, Righini M, LE Gal G. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: A systematic review and meta-analysis. J Thromb Haemost 2011;9:1119-25
  10. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002;88:407-14
  11. Iorio A, Kearon C, Filippucci E, Marcucci M, Macura A, Pengo V, et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: A systematic review. Arch Intern Med 2010;170:1710-6
  12. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: Incidence and risk factors. Arch Intern Med 2000;160:769-74
  13. Kearon C, Spencer FA, O’Keeffe D, Parpia S, Schulman S, Baglin T, et al. D-dimer testing to select patients with a